• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    Alimera Sciences, Inc. (ALIM)

    -NasdaqGM
    4.90 Down 0.31(5.95%) 3:59PM EST
    Add to Portfolio
    Prev Close:5.21
    Open:5.05
    Bid:4.50 x 300
    Ask:5.50 x 900
    1y Target Est:11.00
    Beta:0.92
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:4.50 - 5.05
    52wk Range:4.50 - 8.36
    Volume:488,127
    Avg Vol (3m):176,650
    Market Cap:217.05M
    P/E (ttm):N/A
    EPS (ttm):-1.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALIM

    Comparison

    Symbol% ChgMkt Cap
    ALIMDown 5.95%217.05M
    AGNDown 0.11%70.68B

    Key Statistics

    Forward P/E (1 yr):12.25
    P/S (ttm):30.30
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.58
    Quarterly EPS Est (Mar-15) :-0.21
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alimera Sciences, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback